Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Neoplasm Metastasis 2Melanoma 2Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Patient Preference 1Diabetes Mellitus, Insulin-Dependent, 12 1

Interventions

Ipilimumab 10tremelimumab 6durvalumab 5Nivolumab 3pembrolizumab 2tilsotolimod 1spartalizumab 1relatlimab 1folfirinox 1balstilimab 1Vemurafenib 1Vaccines 1Radiotherapy 1Radiofrequency Ablation 1Radiation 1Paclitaxel 1Oxaliplatin 1Opdualag 1Melphalan 1Leucovorin 1Fluorouracil 1Docetaxel 1Cryosurgery 1Carboplatin 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Diabetes Mellitus, Insulin-Dependent, 12 × Opdualag × Clear all
NCT04326257 2026-01-08

Personalized Immunotherapy in Patients With Recurrent /Metastatic SCCHN That Have Progressed on Prior Immunotherapy

University of Pittsburgh

Phase 2 Completed
20 enrolled 13 charts
Head & Neck

Diabetes Mellitus, Insulin-Dependent, 12, Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡